Along in preclinical trials [46].Present OPINIONAlthough antiplatelet agents such as ASA
Along in preclinical trials .Present OPINIONAlthough antiplatelet agents for example ASA and P2Y12 antagonists are well established for patients with atherothrombotic complications, the threat of thrombotic and ischemic events nevertheless…